4.7 Review

AAA ATPases as therapeutic targets: Structure, functions, and small-molecule inhibitors

期刊

出版社

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2021.113446

关键词

AAA ATPases; Small molecule inhibitors; p97; RUVBL1/2; ATAD2

资金

  1. National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01NS100815, R01NS102279]
  2. National Institute of Child Health and Human Development [R01 HD086596]
  3. National Cancer Institute, National Institutes of Health [75N91019D00024, 75N091019F00129]

向作者/读者索取更多资源

AAA ATPases, essential enzymes found in all organisms, are involved in various cellular activities. Researchers have identified and developed small-molecule inhibitors against these enzymes. Structural information suggests further development of specific AAA ATPase inhibitors in the future.
ATPases Associated with Diverse Cellular Activity (AAA ATPase) are essential enzymes found in all organisms. They are involved in various processes such as DNA replication, protein degradation, membrane fusion, microtubule serving, peroxisome biogenesis, signal transduction, and the regulation of gene expression. Due to the importance of AAA ATPases, several researchers identified and developed small-molecule inhibitors against these enzymes. We discuss six AAA ATPases that are potential drug targets and have well-developed inhibitors. We compare available structures that suggest significant differences of the ATP binding pockets among the AAA ATPases with or without ligand. The distances from ADP to the His20 in the His-Ser-His motif and the Arg finger (Arg353 or Arg378) in both RUVBL1/2 complex structures bound with or without ADP have significant differences, suggesting dramatically different interactions of the binding site with ADP. Taken together, the inhibitors of six well-studied AAA ATPases and their structural information suggest further development of specific AAA ATPase inhibitors due to difference in their structures. Future chemical biology coupled with proteomic approaches could be employed to develop variant specific, complex specific, and pathway specific inhibitors or activators for AAA ATPase proteins. (C) 2021 Elsevier Masson SAS. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据